Should You Buy Tonix Pharmaceuticals Holding Corp (TNXP) Today? Analysis, Price Targets, and 2026 Outlook.
Analysis Updated At
2026/01/26
Tonix Pharmaceuticals Holding Corp (TNXP) is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 to invest. While the company has shown revenue growth and improved net income YoY, the negative EPS trend and lack of significant positive catalysts or trading signals make it a less compelling investment opportunity currently. The technical indicators suggest a neutral trend, and the options data reflects low put-call ratios, indicating limited bullish sentiment. With no recent news or significant insider activity, it is best to hold off on investing in TNXP for now.
Technical Analysis
The MACD is positive and expanding, indicating bullish momentum. RSI is neutral at 65.009, and moving averages are converging, suggesting no clear trend. The stock is trading near resistance levels (R1: 19.188), with a pivot at 17.285 and support at 15.383. Overall, the technical indicators suggest a neutral to slightly bullish trend.
